Clinical Trials in Georgia

Showing 7221-7240 of 19,050 trials

ALPN-202 With PD-1 Inhibition in Advanced Malignancies

NCT04920383

This is a cohort-based, open-label dose escalation and expansion study in adults with advanced solid tumors or lymphoma.

Advanced Solid TumorLymphoma

Alpine Immune Sciences, Inc.29 participantsStarted Jun 2021

Atlanta, Georgia, United States • Boston, Massachusetts, United States • Grand Rapids, Michigan, United States +2 more locations

COMPLETEDPhase 265 miles

A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia

NCT03382639

The purpose of this study is to determine whether add-on luvadaxistat is superior to placebo on the Positive and Negative Syndrome Scale Negative Symptom Factor Score (PANSS NSFS).

Schizophrenia

Neurocrine Biosciences256 participantsStarted Jan 2018

Garden Grove, California, United States • Lemon Grove, California, United States • Los Angeles, California, United States +51 more locations

ALPN-202 With PD-1 Inhibition in Advanced Malignancies

A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia

Find Trials by Condition in Georgia

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

ACS Community Access to Resources Education and Support

The EMPATHY Pilot Study

Extension Study to Evaluate the Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study

Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors

An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis

Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study)

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer

Strategic Timing of Antiretroviral Treatment

RF Ablation of the Trigone for the Treatment of UUI

A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

Cardionomic STOP-ADHF Study

Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY)

NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

A Clinical Trial of PRAX-944 in Participants With Essential Tremor

CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy Adults

A Study to Evaluate the Safety and Tolerability of RO7296682 in Participants With Advanced Solid Tumors